California Public Employees Retirement System’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-307,737
| Closed | -$1.36M | – | 1236 |
|
|
2022
Q2 | $1.36M | Hold |
307,737
| – | – | ﹤0.01% | 1185 |
|
|
2022
Q1 | $2.8M | Sell |
307,737
-76,804
| -20% | -$884K | ﹤0.01% | 1178 |
|
|
2021
Q4 | $7.87M | Sell |
384,541
-54,772
| -12% | -$1.32M | 0.01% | 1074 |
|
|
2021
Q3 | $11.2M | Sell |
439,313
-2,067
| -0.5% | -$61.2K | 0.01% | 944 |
|
|
2021
Q2 | $15.4M | Buy |
441,380
+1,292
| +0.3% | +$37.6K | 0.01% | 795 |
|
|
2021
Q1 | $14.7M | Sell |
440,088
-4,257
| -1% | -$149K | 0.01% | 829 |
|
|
2020
Q4 | $11.5M | Buy |
444,345
+66,702
| +18% | +$1.13M | 0.01% | 937 |
|
|
2020
Q3 | $3.73M | Buy |
377,643
+56,919
| +18% | +$328K | ﹤0.01% | 1444 |
|
|
2020
Q2 | $1.11M | Buy |
320,724
+4,300
| +1% | +$14.6K | ﹤0.01% | 2163 |
|
|
2020
Q1 | $968K | Sell |
316,424
-3,300
| -1% | -$13.5K | ﹤0.01% | 2031 |
|
|
2019
Q4 | $1.64M | Buy |
319,724
+66,700
| +26% | +$339K | ﹤0.01% | 2137 |
|
|
2019
Q3 | $1.31M | Buy |
253,024
+58,382
| +30% | +$327K | ﹤0.01% | 2143 |
|
|
2019
Q2 | $1.18M | Sell |
194,642
-278,963
| -59% | -$1.96M | ﹤0.01% | 2062 |
|
|
2019
Q1 | $3.42M | Buy |
473,605
+31,722
| +7% | +$229K | ﹤0.01% | 1415 |
|
|
2018
Q4 | $3.27M | Hold |
441,883
| – | – | ﹤0.01% | 1395 |
|
|
2018
Q3 | $2.39M | Sell |
441,883
-15,517
| -3% | -$66.6K | ﹤0.01% | 1798 |
|
|
2018
Q2 | $1.62M | Hold |
457,400
| – | – | ﹤0.01% | 2034 |
|
|
2018
Q1 | $938K | Hold |
457,400
| – | – | ﹤0.01% | 2332 |
|
|
2017
Q4 | $1.21M | Hold |
457,400
| – | – | ﹤0.01% | 2223 |
|
|
2017
Q3 | $2.4M | Hold |
457,400
| – | – | ﹤0.01% | 1804 |
|
|
2017
Q2 | $1.63M | Buy |
457,400
+249,900
| +120% | +$1.01M | ﹤0.01% | 1985 |
|
|
2017
Q1 | $1.07M | Sell |
207,500
-9,000
| -4% | -$44.1K | ﹤0.01% | 2254 |
|
|
2016
Q4 | $823K | Sell |
216,500
-11,200
| -5% | -$81.4K | ﹤0.01% | 2436 |
|
|
2016
Q3 | $2.04M | Sell |
227,700
-15,600
| -6% | -$130K | ﹤0.01% | 1911 |
|
|
2016
Q2 | $1.71M | Sell |
243,300
-7,600
| -3% | -$69.4K | ﹤0.01% | 2006 |
|
|
2016
Q1 | $2.13M | Sell |
250,900
-15,200
| -6% | -$149K | ﹤0.01% | 1858 |
|
|
2015
Q4 | $3.49M | Hold |
266,100
| – | – | 0.01% | 1548 |
|
|
2015
Q3 | $974K | Sell |
266,100
-8,950
| -3% | -$43.8K | ﹤0.01% | 2386 |
|
|
2015
Q2 | $1.58M | Hold |
275,050
| – | – | ﹤0.01% | 2209 |
|
|
2015
Q1 | $2.27M | Hold |
275,050
| – | – | ﹤0.01% | 2044 |
|
|
2014
Q4 | $2.27M | Hold |
275,050
| – | – | ﹤0.01% | 2044 |
|
|
2014
Q3 | $1.35M | Hold |
275,050
| – | – | ﹤0.01% | 2318 |
|
|
2014
Q2 | $1.7M | Hold |
275,050
| – | – | ﹤0.01% | 2206 |
|
|
2014
Q1 | $1.26M | Sell |
275,050
-228,550
| -45% | -$1.44M | ﹤0.01% | 2387 |
|
|
2013
Q4 | $2.56M | Sell |
503,600
-1,400
| -0.3% | -$6.43K | ﹤0.01% | 1903 |
|
|
2013
Q3 | $2.79M | Hold |
505,000
| – | – | 0.01% | 1689 |
|
|
2013
Q2 | $1.27M | Buy |
+505,000
| New | +$1.26M | ﹤0.01% | 2089 |
|
Other funds holding PACB
JSP
California Public Employees Retirement System's PACB Position: Q3 2022 in Review
California Public Employees Retirement System sold out of Pacific Biosciences (PACB) in Q3 2022, closing a stake of 307,737 shares — an estimated $1.36M sold.
California Public Employees Retirement System first reported a position in PACB in Q2 2013 and held it in 37 quarters. The position peaked at $15.4M in Q2 2021. 226 funds tracked by Wall St. Rank hold PACB as of Q3 2022.
- California Public Employees Retirement System reported no remaining Pacific Biosciences position as of Q3 2022 after selling out during the quarter.
- California Public Employees Retirement System sold 307,737 Pacific Biosciences shares in Q3 2022, an estimated $1.36M.
- California Public Employees Retirement System first reported a position in Pacific Biosciences in Q2 2013 and held it in 37 quarters.
- California Public Employees Retirement System's Pacific Biosciences position peaked at $15.4M in Q2 2021.
- 226 funds tracked by Wall St. Rank held Pacific Biosciences as of Q3 2022.
Based on California Public Employees Retirement System's 13F filing for Q3 2022, filed 9 Nov 2022.